๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Carcinoma of the superior pulmonary sulcus treated with surgery and/or radiation therapy

โœ Scribed by John W. Devine; William M. Mendenhall; Rodney R. Million; Michael J. Carmichael


Publisher
John Wiley and Sons
Year
1986
Tongue
English
Weight
334 KB
Volume
57
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Squamous cell carcinoma of the maxillary
โœ Jun Itami; Takashi Uno; Moriyo Aruga; Shigeomi Ode ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 82 KB ๐Ÿ‘ 1 views

## Squamous Cell Carcinoma of the Maxillary Sinus Treated with Radiation Therapy and Conservative Surgery BACKGROUND. For patients with squamous cell carcinoma of the maxillary sinus, Jun Itami, M

Sequential surgery, radiation therapy, a
โœ Roger Potish; Leon Adcock; Doris Brooker; Thomas K. Jones Jr.; Seymour H. Levitt ๐Ÿ“‚ Article ๐Ÿ“… 1980 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 418 KB ๐Ÿ‘ 1 views

In 1970, a prospective multidisciplinary protocol was initiated for Stages I through III obviously malignant ovarian epithelial carcinomas. The planned sequential therapy included 1) surgery, 2) radiotherapy (2000 rads to whole abdomen, 3000 rad boost to pelvis), 3) chemotherapy (ten cycles of Alker

The relation between the presence and ex
โœ Anthony L. Abner; James L. Connolly; Abram Recht; Bruce Bornstein; Asa Nixon; St ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 72 KB ๐Ÿ‘ 2 views

## Background: When found in an otherwise benign biopsy, lobular carcinoma in situ (lcis) has been associated with an increased risk of development of a subsequent invasive breast carcinoma. however, the association between lcis and the risk of subsequent local recurrence in patients with infiltrat

A randomized trial of long term adjuvant
โœ Kristina Dalberg; Hemming Johansson; Ulla Johansson; Lars E. Rutqvist ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 101 KB ๐Ÿ‘ 2 views

## BACKGROUND. The use of adjuvant tamoxifen to treat postmenopausal breast carcinoma patients as an adjunct to primary surgery is well established. The current study reports the long term results for a low risk stratum in a randomized trial of adjuvant tamoxifen. The main focus of this analysis w